Effects of in-vitro activity of miconazole and ketoconazole in phospholipid formulations

Antifungal agents are often used in liposomal formulations in order to improve their pharmacological activity, but how vesicle inclusion can actually affect this is still not fully understood. We report here the results obtained from evaluation of the in-vitro activity against Candida albicans ATCC...

Full description

Saved in:
Bibliographic Details
Published in:Journal of antimicrobial chemotherapy 1997-12, Vol.40 (6), p.889-893
Main Authors: DE LOGU, A, FADDA, A. M, ANCHISI, C, MACCIONI, A. M, SINICO, C, SCHIVO, M. L, ALHAIQUE, F
Format: Article
Language:English
Subjects:
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antifungal Agents
Biological and medical sciences
Candida albicans - drug effects
Drug Carriers
Ketoconazole - pharmacology
Medical sciences
Miconazole - pharmacology
Microbial Sensitivity Tests
Pharmacology. Drug treatments
Phospholipids
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c384t-363730b3be0a40ba217b0abb1b94def5b1e98a53259773ce94d32733d36dbd9b3
cites
container_end_page 893
container_issue 6
container_start_page 889
container_title Journal of antimicrobial chemotherapy
container_volume 40
creator DE LOGU, A
FADDA, A. M
ANCHISI, C
MACCIONI, A. M
SINICO, C
SCHIVO, M. L
ALHAIQUE, F
description Antifungal agents are often used in liposomal formulations in order to improve their pharmacological activity, but how vesicle inclusion can actually affect this is still not fully understood. We report here the results obtained from evaluation of the in-vitro activity against Candida albicans ATCC E10231 of miconazole and ketoconazole in various vesicular and non-vesicular preparations, obtained from egg and soya phospholipids, using time-kill curves. In most cases inclusion of miconazole or ketoconazole in liposomes led to a delayed and decreased activity of the drugs, with detectable differences among the various phospholipid concentrations and different liposomal preparations (small unilamellar vesicle, liposomes, multilamellar aggregates and broken liposomal structures). The results obtained may be helpful in the study of new preparations of antifungal agents entrapped in liposomal structures.
doi_str_mv 10.1093/jac/40.6.889
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79546657</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16269704</sourcerecordid><originalsourceid>FETCH-LOGICAL-c384t-363730b3be0a40ba217b0abb1b94def5b1e98a53259773ce94d32733d36dbd9b3</originalsourceid><addsrcrecordid>eNqFkE1Lw0AQhhdRaq3evAo5iCfTzma_skcp9QMKXhS8LbubDW5NsjGbCvXXm9LQq4dhhvd9mMOD0DWGOQZJFhttFxTmfJ7n8gRNMeWQZiDxKZoCAZYKysg5uohxAwCc8XyCJpLyjFI6RR-rsnS2j0koE9-kP77vQqJt74drtw9rb0Ojf0PlEt0UyZfrwzHwTdJ-hjhM5VtfJGXo6m2lex-aeInOSl1FdzXuGXp_XL0tn9P169PL8mGdWpLTPiWcCAKGGAeagtEZFga0MdhIWriSGexkrhnJmBSCWDekJBOEFIQXppCGzNDd4W_bhe-ti72qfbSuqnTjwjYqIRnlnIl_QcwzLgXQAbw_gLYLMXauVG3na93tFAa1N64G44qC4mowPuA349-tqV1xhEfFQ3879jpaXZWdbqyPRyzDwLgE8gfzzon8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16269704</pqid></control><display><type>article</type><title>Effects of in-vitro activity of miconazole and ketoconazole in phospholipid formulations</title><source>Oxford Journals Online</source><creator>DE LOGU, A ; FADDA, A. M ; ANCHISI, C ; MACCIONI, A. M ; SINICO, C ; SCHIVO, M. L ; ALHAIQUE, F</creator><creatorcontrib>DE LOGU, A ; FADDA, A. M ; ANCHISI, C ; MACCIONI, A. M ; SINICO, C ; SCHIVO, M. L ; ALHAIQUE, F</creatorcontrib><description>Antifungal agents are often used in liposomal formulations in order to improve their pharmacological activity, but how vesicle inclusion can actually affect this is still not fully understood. We report here the results obtained from evaluation of the in-vitro activity against Candida albicans ATCC E10231 of miconazole and ketoconazole in various vesicular and non-vesicular preparations, obtained from egg and soya phospholipids, using time-kill curves. In most cases inclusion of miconazole or ketoconazole in liposomes led to a delayed and decreased activity of the drugs, with detectable differences among the various phospholipid concentrations and different liposomal preparations (small unilamellar vesicle, liposomes, multilamellar aggregates and broken liposomal structures). The results obtained may be helpful in the study of new preparations of antifungal agents entrapped in liposomal structures.</description><identifier>ISSN: 0305-7453</identifier><identifier>ISSN: 1460-2091</identifier><identifier>EISSN: 1460-2091</identifier><identifier>DOI: 10.1093/jac/40.6.889</identifier><identifier>PMID: 9462444</identifier><identifier>CODEN: JACHDX</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antifungal Agents ; Biological and medical sciences ; Candida albicans - drug effects ; Drug Carriers ; Ketoconazole - pharmacology ; Medical sciences ; Miconazole - pharmacology ; Microbial Sensitivity Tests ; Pharmacology. Drug treatments ; Phospholipids</subject><ispartof>Journal of antimicrobial chemotherapy, 1997-12, Vol.40 (6), p.889-893</ispartof><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c384t-363730b3be0a40ba217b0abb1b94def5b1e98a53259773ce94d32733d36dbd9b3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2105690$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9462444$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DE LOGU, A</creatorcontrib><creatorcontrib>FADDA, A. M</creatorcontrib><creatorcontrib>ANCHISI, C</creatorcontrib><creatorcontrib>MACCIONI, A. M</creatorcontrib><creatorcontrib>SINICO, C</creatorcontrib><creatorcontrib>SCHIVO, M. L</creatorcontrib><creatorcontrib>ALHAIQUE, F</creatorcontrib><title>Effects of in-vitro activity of miconazole and ketoconazole in phospholipid formulations</title><title>Journal of antimicrobial chemotherapy</title><addtitle>J Antimicrob Chemother</addtitle><description>Antifungal agents are often used in liposomal formulations in order to improve their pharmacological activity, but how vesicle inclusion can actually affect this is still not fully understood. We report here the results obtained from evaluation of the in-vitro activity against Candida albicans ATCC E10231 of miconazole and ketoconazole in various vesicular and non-vesicular preparations, obtained from egg and soya phospholipids, using time-kill curves. In most cases inclusion of miconazole or ketoconazole in liposomes led to a delayed and decreased activity of the drugs, with detectable differences among the various phospholipid concentrations and different liposomal preparations (small unilamellar vesicle, liposomes, multilamellar aggregates and broken liposomal structures). The results obtained may be helpful in the study of new preparations of antifungal agents entrapped in liposomal structures.</description><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antifungal Agents</subject><subject>Biological and medical sciences</subject><subject>Candida albicans - drug effects</subject><subject>Drug Carriers</subject><subject>Ketoconazole - pharmacology</subject><subject>Medical sciences</subject><subject>Miconazole - pharmacology</subject><subject>Microbial Sensitivity Tests</subject><subject>Pharmacology. Drug treatments</subject><subject>Phospholipids</subject><issn>0305-7453</issn><issn>1460-2091</issn><issn>1460-2091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNqFkE1Lw0AQhhdRaq3evAo5iCfTzma_skcp9QMKXhS8LbubDW5NsjGbCvXXm9LQq4dhhvd9mMOD0DWGOQZJFhttFxTmfJ7n8gRNMeWQZiDxKZoCAZYKysg5uohxAwCc8XyCJpLyjFI6RR-rsnS2j0koE9-kP77vQqJt74drtw9rb0Ojf0PlEt0UyZfrwzHwTdJ-hjhM5VtfJGXo6m2lex-aeInOSl1FdzXuGXp_XL0tn9P169PL8mGdWpLTPiWcCAKGGAeagtEZFga0MdhIWriSGexkrhnJmBSCWDekJBOEFIQXppCGzNDd4W_bhe-ti72qfbSuqnTjwjYqIRnlnIl_QcwzLgXQAbw_gLYLMXauVG3na93tFAa1N64G44qC4mowPuA349-tqV1xhEfFQ3879jpaXZWdbqyPRyzDwLgE8gfzzon8</recordid><startdate>19971201</startdate><enddate>19971201</enddate><creator>DE LOGU, A</creator><creator>FADDA, A. M</creator><creator>ANCHISI, C</creator><creator>MACCIONI, A. M</creator><creator>SINICO, C</creator><creator>SCHIVO, M. L</creator><creator>ALHAIQUE, F</creator><general>Oxford University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19971201</creationdate><title>Effects of in-vitro activity of miconazole and ketoconazole in phospholipid formulations</title><author>DE LOGU, A ; FADDA, A. M ; ANCHISI, C ; MACCIONI, A. M ; SINICO, C ; SCHIVO, M. L ; ALHAIQUE, F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c384t-363730b3be0a40ba217b0abb1b94def5b1e98a53259773ce94d32733d36dbd9b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antifungal Agents</topic><topic>Biological and medical sciences</topic><topic>Candida albicans - drug effects</topic><topic>Drug Carriers</topic><topic>Ketoconazole - pharmacology</topic><topic>Medical sciences</topic><topic>Miconazole - pharmacology</topic><topic>Microbial Sensitivity Tests</topic><topic>Pharmacology. Drug treatments</topic><topic>Phospholipids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DE LOGU, A</creatorcontrib><creatorcontrib>FADDA, A. M</creatorcontrib><creatorcontrib>ANCHISI, C</creatorcontrib><creatorcontrib>MACCIONI, A. M</creatorcontrib><creatorcontrib>SINICO, C</creatorcontrib><creatorcontrib>SCHIVO, M. L</creatorcontrib><creatorcontrib>ALHAIQUE, F</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of antimicrobial chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DE LOGU, A</au><au>FADDA, A. M</au><au>ANCHISI, C</au><au>MACCIONI, A. M</au><au>SINICO, C</au><au>SCHIVO, M. L</au><au>ALHAIQUE, F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of in-vitro activity of miconazole and ketoconazole in phospholipid formulations</atitle><jtitle>Journal of antimicrobial chemotherapy</jtitle><addtitle>J Antimicrob Chemother</addtitle><date>1997-12-01</date><risdate>1997</risdate><volume>40</volume><issue>6</issue><spage>889</spage><epage>893</epage><pages>889-893</pages><issn>0305-7453</issn><issn>1460-2091</issn><eissn>1460-2091</eissn><coden>JACHDX</coden><abstract>Antifungal agents are often used in liposomal formulations in order to improve their pharmacological activity, but how vesicle inclusion can actually affect this is still not fully understood. We report here the results obtained from evaluation of the in-vitro activity against Candida albicans ATCC E10231 of miconazole and ketoconazole in various vesicular and non-vesicular preparations, obtained from egg and soya phospholipids, using time-kill curves. In most cases inclusion of miconazole or ketoconazole in liposomes led to a delayed and decreased activity of the drugs, with detectable differences among the various phospholipid concentrations and different liposomal preparations (small unilamellar vesicle, liposomes, multilamellar aggregates and broken liposomal structures). The results obtained may be helpful in the study of new preparations of antifungal agents entrapped in liposomal structures.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>9462444</pmid><doi>10.1093/jac/40.6.889</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0305-7453
ispartof Journal of antimicrobial chemotherapy, 1997-12, Vol.40 (6), p.889-893
issn 0305-7453
1460-2091
1460-2091
language eng
recordid cdi_proquest_miscellaneous_79546657
source Oxford Journals Online
subjects Antibiotics. Antiinfectious agents. Antiparasitic agents
Antifungal Agents
Biological and medical sciences
Candida albicans - drug effects
Drug Carriers
Ketoconazole - pharmacology
Medical sciences
Miconazole - pharmacology
Microbial Sensitivity Tests
Pharmacology. Drug treatments
Phospholipids
title Effects of in-vitro activity of miconazole and ketoconazole in phospholipid formulations
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T13%3A19%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20in-vitro%20activity%20of%20miconazole%20and%20ketoconazole%20in%20phospholipid%20formulations&rft.jtitle=Journal%20of%20antimicrobial%20chemotherapy&rft.au=DE%20LOGU,%20A&rft.date=1997-12-01&rft.volume=40&rft.issue=6&rft.spage=889&rft.epage=893&rft.pages=889-893&rft.issn=0305-7453&rft.eissn=1460-2091&rft.coden=JACHDX&rft_id=info:doi/10.1093/jac/40.6.889&rft_dat=%3Cproquest_cross%3E16269704%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c384t-363730b3be0a40ba217b0abb1b94def5b1e98a53259773ce94d32733d36dbd9b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=16269704&rft_id=info:pmid/9462444&rfr_iscdi=true